ATRO Medical Named Awardee in the Johnson & Johnson Innovation Veterans Lead QuickFire Challenge
Yess!! ATRO Medical has been named an Awardee in the Veterans Lead QuickFire Challenge organized by Johnson & Johnson Innovation!
May 12th, 2022
What a great recognition for our team of the potential benefit that our meniscus prosthesis may have for Veterans. The incidence of knee osteoarthritis is known to be 10 times higher under military personnel compared to civilians. This is highly correlated to meniscus damage. And almost 20% of those who need surgical meniscus repair will leave the army within 2.5 years.
We would be honored if our Trammpolin® Meniscus Prosthesis could play a part in providing pain relief for these veterans. Besides the recognition, this award comes with grant funding, which will be spent on accelerating the development of the lateral meniscus prosthesis.
The lateral (outside) compartment of the knee joint is known for its’ fast cartilage degradation in a meniscus- deficient knee. It is of utmost importance to provide an early surgical solution for this lateral side since the severity of complaints and disease related health costs increase with ongoing cartilage degradation.
The Dutch startup ATRO Medical is entirely focused on creating a durable solution for patients suffering from the post-meniscectomy pain syndrome. Their meniscus prosthesis under development has already received FDA breakthrough device designation, the EU Seal of Excellence and the MedTech Innovator finalist award by AdvaMed. Their medial prosthesis is currently under investigation in a prospective clinical study in the Netherlands.
**Trammpolin® is nowadays known as Artimis®
1.DOI 10.7205/MILMED-D-15-00589 2.DOI 10.1177/0363546515612076 3.DOI 10.1002/acr.22412
Share this article
Do you want to read more?
View related articles here
Dutch meniscus prosthesis receives FDA Breakthrough Device Designation
Patients
Dutch medical innovations are rarely granted the Breakthrough Designation by the FDA. Startup ATRO Medical from Nijmegen is the new kid on the block in orthopedics. This week their Trammpolin® meniscus prosthesis (nowadays known as Artimis®), designed to treat chronic knee pain, received the Breakthrough Device Designation from the FDA. The designation demonstrates the innovation potential of this implant and expedites US market access by receiving a priority treatment at the FDA.
EUROSTARS grants funding for first lateral meniscus prosthesis
Professionals
An international consortium led by the Dutch med-tech startup ATRO Medical receives over € 800,000 EUROSTARS funding to address an unmet need for Knee Osteoarthritis patients. These patients often suffer from cartilage degradation related to a dysfunctional meniscus. Based on previous research, the consortium will develop a durable meniscus prosthesis for the outer knee compartment to relief pain and restore mobility. This would change the life of thousands of osteoarthritis patients.
ATRO Medical Named Awardee in the Johnson & Johnson Innovation Veterans Lead QuickFire Challenge
Professionals
Yess!! ATRO Medical has been named an Awardee in the Veterans Lead QuickFire Challenge organized by Johnson & Johnson Innovation!
The Dutch Arthritis Society supports further development of the meniscus prosthesis of ATRO Medical
Patients
Orthopedic startup ATRO Medical enters a partnership together with the Dutch Arthritis Society for further development of the artificial meniscus. The Dutch startup works on a meniscus prosthesis for people with knee arthritis. The Dutch Arthritis Society supports these developments and shares its experience as patient expert in the field of arthritis.
Meniscus prosthesis receives € 2.5 million EU grant
Professionals
The European Commission grants € 2.5 million to ATRO Medical for the accelerated development of their artificial meniscus. The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain. Their ground-breaking innovation continues to attract international attention, paving the way towards full-scale healthcare implementation.
ATRO Medical B.V.
We are an innovative medical device company that was was founded in 2016. The lead product is the Artimis® meniscus prosthesis.
Contact details
Novio Tech Campus
Transistorweg 5, 6534 AT Nijmegen (Headquarters)
Liessentstraat 9a, 5405 AH Uden (Registered office)
info@atromedical.com
Navigation
Newsletter
Stay informed of the latest news and development regarding Artimis®!
